The world can say goodbye to tuberculosis by 2045. An international team of specialists said Wednesday that if proper support is available, it’s possible to kill tuberculosis by more than 2 decades
The team underlines that every year more than 10 million cases every year are reported. However, better screening, treatments and public awareness can help. This killer chronic lung disease kills over 1.6 million people every year. It affects the lungs, but can also affect other parts of the body.
The sad thing is, there has not been a commercially available tuberculosis vaccine in a century. In addition, only around 10 percent of the research funding is available for the disease.
An international team of experts suggests that nearly $3 billion per year funding is needed for research and development to properly fight against the killer disease.
“Even if we use the tools we have today it’s not going to be enough. The goal is to end tuberculosis but the current decline is only 1.5-2.0 percent a year,” said Paula Fujiwara, scientific director at The International Union Against Tuberculosis and Lung Disease.
A new treatment approach for drug-resistant strains of tuberculosis showed successful results in saving 80 percent of sufferers in Belarus. In fact, British pharmaceutical giant GlaxoSmithKline, in its study, showed that a new vaccine worked effectively in 54 percent of trial participants.
“The inevitability is that we will need new drugs as the disease evolves,” Eric Goosby, the United Nations’ special envoy for the disease stated.